FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/29/2023
Back to search
Official data from USPTO
NEORNAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
03/29/2023
Trademark type
Combined
Nice classes
5, 42
Filing date
06/24/2021
Registration date
11/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2022
Last transaction
11/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Seoul, KR
Examiner
STADELI, MARTA ANN
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "NEORNAT" in indigo stylized font with the letter "E" formed by three horizontal indigo lines.
Holders and representatives
Holders
NEORNAT
Representatives
Leigh Ann Lindquist Sughrue Mion PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-cancer preparations; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; diagnostic agents for pharmaceutical use; drug delivery agents in the form of in the form of tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugspharmaceutical preparations for the treatment of cancer; medicines for human purposes for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for use in oncology; pharmaceuticals for the treatment of cancer; non-prescription medicines for the treatment of cancer; biological preparations for the treatment of cancer
Class 42
Scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; consultancy relating to research in the field of pharmacogenetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consulting services in the field of pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; medical laboratory services; medical research laboratory services
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/08/2023
FIMP
FINAL DISPOSITION PROCESSED
03/08/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/15/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/15/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/15/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/30/2022
PUBO
PUBLISHED FOR OPPOSITION
08/30/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/27/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/27/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/27/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/27/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/27/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/22/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/22/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/20/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/20/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/20/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/20/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/20/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/20/2022
RFNT
REFUSAL PROCESSED BY IB
05/24/2022
ATRV
ATTORNEY REVIEW COMPLETED
05/16/2022
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
05/16/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/04/2022
RFRR
REFUSAL PROCESSED BY MPU
05/04/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
04/09/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/23/2022
CNRT
NON-FINAL ACTION WRITTEN
03/22/2022
DOCK
ASSIGNED TO EXAMINER
03/16/2022
MAFR
APPLICATION FILING RECEIPT MAILED
08/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/05/2021
Continuous trademark protection
Get notified about every new filing that threatens NEORNAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.